Statistics
Publications
119
Citations
31.5K
H-Index
59
Active since
1996
Titus J. Boggon is an author at Yale University specializing in medicine, cell biology, and cell signaling.
Publications per year
1996–2023
119
119
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee et al. · Science · 2004 · 9.4K citations
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text
Ross L. Levine, Martha Wadleigh, Jan Cools et al. · Cancer Cell · 2005 · 3K citations · Full text
Hematological Malignancy, Polycythemia Vera, Essential Thrombocythemia +11
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang, Jae Cheol Lee, Luping Lin et al. · Nature Genetics · 2012 · 1.2K citations · Full text
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer, Yong Kong, Byung Hak Ha et al. · Nature Genetics · 2012 · 1.2K citations · Full text
1–5 of 119